Karina G. Godoy-Armenta, Unidad de Medicina Familiar No. 16, IMSS, Querétaro, Qro., México
Laura A. Cu-Flores, Unidad de Medicina Familiar No. 2, Consulta Familiar, IMSS, Querétaro, Qro., México
Liliana Galicia-Rodríguez, Unidad de Investigación Epidemiológica y en Servicios de Salud Querétaro, IMSS, Querétaro, Qro., México
Enrique Villarreal-Ríos, Unidad de Investigación Epidemiológica y en Servicios de Salud Querétaro, IMSS, Querétaro, Qro., México
Background: Cardiovascular risk measures the likelihood of adverse events related to the heart and blood vessels. It has been noted that COVID-19 can cause medium- and long-term sequelae, including cardiovascular disturbances. Objective: To determine the modification of cardiovascular risk following COVID-19 in patients with systemic arterial hypertension. Method: Before-and-after design in patients diagnosed with hypertension who contracted COVID-19, attended on an outpatient basis at a social security institution in Querétaro, Mexico (2021-2022). Cardiovascular risk was evaluated using the ASCVD Risk Calculator from the American College of Cardiology, categorizing it into low (≤ 5%), borderline (5.1-7.4%), intermediate (7.5-19.9%), and high (≥ 20%). Results: A total of 300 patients were evaluated. In 80.4%, cardiovascular risk remained unchanged, while in 12.3% it increased, and in 7.3% it decreased. Conclusions: COVID-19 can modify cardiovascular risk in patients with systemic arterial hypertension, highlighting the importance of close monitoring in this population.
Keywords: Cardiovascular risk. Arterial hypertension. COVID-19.